Antitumor Activity of Ficlatuzumab in Combination with Tivozanib On Primary Human Renal Cell Carcinoma Xenografts

被引：0
|
作者：
Meetze, K. [1 ]
Connolly, K. [1 ]
Feng, B. [1 ]
Rideout, W. [1 ]
Gyuris, J. [1 ]
Han, M. [1 ]
机构：
[1] AVEO Pharmaceut Inc, Drug Discovery, Cambridge, MA USA
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
301
引用
收藏
页码：92 / 92
页数：1
相关论文
共 50 条
  • [41] IL-37 mediates the antitumor activity in renal cell carcinoma
    Yazhuo Jiang
    Yili Wang
    Liang Liang
    Yang Gao
    Juan Chen
    Yi Sun
    Yongyi Cheng
    Yonggang Xu
    Medical Oncology, 2015, 32
  • [42] Antitumor activity of CP-4055 is enhanced in combination with bevacizumab, cetuximab, and trastuzumab in human NSCLC xenografts
    Bruheim, Skjalg
    Maelandsmo, Gunhild M.
    Sandvold, Marit Liland
    Myhren, Finn
    Fodstad, Oystein
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3523S - 3524S
  • [43] IL-37 mediates the antitumor activity in renal cell carcinoma
    Jiang, Yazhuo
    Wang, Yili
    Liang, Liang
    Gao, Yang
    Chen, Juan
    Sun, Yi
    Cheng, Yongyi
    Xu, Yonggang
    MEDICAL ONCOLOGY, 2015, 32 (11)
  • [44] XENOGRAFTS OF PRIMARY HUMAN PROSTATIC-CARCINOMA
    PRETLOW, TG
    WOLMAN, SR
    MICALE, MA
    PELLEY, RJ
    KURSH, ED
    RESNICK, MI
    BODNER, DR
    JACOBBERGER, JW
    DELMORO, CM
    GIACONIA, JM
    PRETLOW, TP
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) : 394 - 402
  • [45] Antitumor and Antiangiogenic Activity of Cediranib in a Preclinical Model of Renal Cell Carcinoma
    Medinger, Michael
    Esser, Norbert
    Zirrgiebel, Ute
    Ryan, Anderson
    Juergensmeier, Juliane M.
    Drevs, Joachim
    ANTICANCER RESEARCH, 2009, 29 (12) : 5065 - 5076
  • [46] Antitumor activity of atrasentan, a selective endothelin A receptor antagonist, in combination with cytotoxic agents in ovarian carcinoma xenografts.
    Rosanò, L
    Spinella, F
    De Castro, V
    Nicotra, MR
    Natali, PG
    Bagnato, A
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6236S - 6236S
  • [47] Telomerase activity in human renal cell carcinoma
    Mehle, C
    Piatyszek, MA
    Ljungberg, B
    Shay, JW
    Roos, G
    ONCOGENE, 1996, 13 (01) : 161 - 166
  • [48] Telomerase activity in human renal cell carcinoma
    Sugimura, K
    Yoshida, N
    Hisatomi, H
    Nakatani, T
    Ikemoto, S
    BJU INTERNATIONAL, 1999, 83 (06) : 693 - 697
  • [49] Telomerase activity in human renal cell carcinoma
    Fujioka, T
    Hasegawa, M
    Suzuki, Y
    Suzuki, T
    Sugimura, J
    Tanji, S
    Koike, H
    INTERNATIONAL JOURNAL OF UROLOGY, 2000, 7 (01) : 16 - 21
  • [50] Antitumor activity of cetuximab (Erbitux TM) in human carcinoma xenografts: Potentiation in combination with cisplatin and comparisons with gefitinib (ZD1839) monotherapy.
    Wild, R
    Kan, D
    Inigo, I
    Castaneda, S
    Fager, K
    Lee, FY
    Rose, WC
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6100S - 6100S
12345